<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is a ubiquitous human gamma herpesvirus that is associated with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), gastric <z:mp ids='MP_0002038'>carcinoma</z:mp>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC), and NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Two <z:mp ids='MP_0001799'>viral</z:mp> promoters, Cp and Qp, are important for EBV <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The latency Cp, which is used in <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e>, drives expression of the full spectrum of EBV nuclear antigens </plain></SENT>
<SENT sid="3" pm="."><plain>Qp is active in EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and drives the latency I/II expression pattern </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we determined <z:chebi fb="9" ids="36976">nucleotides</z:chebi> polymorphisms in the Cp and Qp promoter regions in peripheral blood mononuclear cells (PBMCs) from Cantonese healthy carriers and in biopsies of NPC, nasal NK/T <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, and gastric <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The sequence changes of -12G&gt;T and +69 C&gt;T in Cp and -197 G&gt;A and +1 G&gt;C in Qp were frequently identified in NPC </plain></SENT>
<SENT sid="6" pm="."><plain>Transient transfection studies using luciferase gene reporters revealed a significant reduction (57.11%) in gene expression from the Cp +69T variant and increased expression (43.5%) from the Qp +1C variant compared to the prototype, suggesting that these sequence variations affect promoter activity </plain></SENT>
<SENT sid="7" pm="."><plain>Our results indicate that the <z:chebi fb="9" ids="36976">nucleotides</z:chebi> polymorphisms in Cp and Qp occur frequently in NPC and might contribute to the <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> of EBV </plain></SENT>
</text></document>